project id: TCGA-BRCA; case submitter id: TCGA-B6-A3ZX; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.8; concentration: 0.16; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.64; rna integrity number: 9.3; age at index: 50; days to birth: -18434; days to death: 1152; ethnicity: not hispanic or latino; gender: female; race: black or african american; vital status: Dead; year of birth: 1957; age at diagnosis: 18434; ajcc pathologic m: M1; ajcc pathologic n: N1; ajcc pathologic stage: Stage IV; ajcc pathologic t: T3; ajcc staging system edition: 6th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 1132.0; icd 10 code: C50.9; last known disease status: not reported; morphology: 8522/3; primary diagnosis: Infiltrating duct and lobular carcinoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Breast, NOS; synchronous malignancy: No; tissue or organ of origin: Breast, NOS; tumor grade: Not Reported; year of diagnosis: 2007; treatment or therapy: yes; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 1954; initial weight: 5.0; sample id: 38f37f0c-75d2-4a56-b62a-9472a9c3ae13; sample submitter id: TCGA-B6-A3ZX-01A; portion id: 98777fce-4546-4aec-bc74-d6cbd41706b5; portion submitter id: TCGA-B6-A3ZX-01A-11; slide id: 68f70986-83f0-4b65-aff5-496b0c60270f; slide submitter id: TCGA-B6-A3ZX-01A-01-TS1; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 100.0; percent tumor nuclei: 75.0; section location: TOP;